Kratom Detection Window in Urine Drug Screens
Standard urine drug screens (UDS) do not detect kratom at all, as kratom alkaloids (mitragynine and its metabolites) are not included in routine drug testing panels. If specialized kratom testing is ordered, the urine will typically become negative approximately 5-7 days after last use for occasional users, though this can extend longer in chronic users.
Key Clinical Points
Standard UDS Panels Do Not Detect Kratom
The general drug testing guidelines 1 describe standard substance detection but do not include kratom in routine panels. Kratom requires specialized testing specifically designed to detect mitragynine and its metabolites 2, 3. This is a critical pitfall—clinicians cannot rely on standard workplace or clinical UDS panels to detect kratom use.
Detection Window for Specialized Kratom Testing
When specialized kratom testing is performed:
- Terminal half-life of mitragynine: Approximately 23 hours (range: 7-39 hours) 4
- Primary excretion: Predominantly as metabolites (7-hydroxymitragynine and others), with only 0.14% excreted unchanged in urine 4
- Detection window: Based on pharmacokinetic data showing a ~1-day half-life, kratom metabolites should be detectable for approximately 5-7 days after last use in occasional users 4
- Chronic users: May have prolonged detection due to accumulation, potentially extending beyond 7 days
Metabolite Considerations
The urine contains multiple kratom alkaloid metabolites including:
- 16-carboxy-mitragynine
- 9-O-demethyl-mitragynine
- 9-O-demethyl-16-carboxy-mitragynine
- Speciogynine, speciociliatine, and their metabolites 2, 3
7-hydroxymitragynine appears in higher urine concentrations than the parent compound mitragynine 5, making it a more reliable marker for detection.
Testing Method Matters
- Over-the-counter kratom urine tests: Have shown 100% sensitivity and specificity in detecting kratom metabolites when compared to LC-MS/MS 5, though this data is limited
- Laboratory-based LC-MS/MS: Gold standard for confirmation and can detect all diastereomers 3
- Detection sensitivity: Methods can typically detect kratom metabolites at low nanogram/mL levels 2
Clinical Caveats
A negative standard UDS does not exclude kratom use. If kratom use is suspected clinically, you must specifically order kratom testing 1. The general principle that "a single negative drug test result does not exclude the possibility of drug use" 1 is particularly relevant here given kratom's absence from standard panels.
Factors affecting detection time include:
- Dose and frequency of use
- Individual metabolic variation
- Urine concentration (creatinine 2-20 mg/mL is normal range) 1
- Hydration status